BioSpace News Archive

Business

Pfizer Inks Manufacturing Deals with Samsung Biologics Worth Nearly $900M

The pharmaceutical giant is tapping the world’s largest biomanufacturing facility operated by Samsung Biologics for biosimilar production.

July 5, 2023
·
2 min read
·
Tristan Manalac
Editorial: Gen Z Works for the Money—And You Should, Too

The youngest generation to enter the workforce has mastered working to live, not living to work. Adopting this mindset made me not only more fulfilled, but more successful in my career.

July 5, 2023
·
5 min read
·
Rosemary Scott
Policy

Amgen, Horizon Hit Back at FTC Lawsuit Seeking to Block Merger

The companies have filed their own suit against the Federal Trade Commission, claiming the FTC’s attempt to legally block their $28 billion merger is unconstitutional.

July 5, 2023
·
2 min read
·
Tristan Manalac
Policy

FDA Rejects Amneal’s Extended-Release Parkinson’s Drug

Citing insufficient safety evidence for one of the drug’s main ingredients, the regulator in a Complete Response Letter rejected the company’s application for Parkinson’s disease candidate IPX203.

July 5, 2023
·
2 min read
·
Tristan Manalac
Aroga Biosciences Recognized as Top 10 Medical Writing Services Provider by Life Sciences Review

The regulatory medical writing firm is being acknowledged by industry for outstanding service and specialized commitment to its biotechnology and pharmaceutical partners.

July 5, 2023
·
2 min read
Business

Moderna Signs $1B Deal to Develop mRNA Drugs for China

The company has signed a memorandum of understanding and land collaboration agreement to develop medicines exclusively for Chinese use.

July 5, 2023
·
2 min read
·
Connor Lynch
Biotech Beach

Palisade Bio Announces Completion of Enrollment in LB1148 Dose Optimization Study

Palisade Bio, Inc. today announced the completion of patient enrollment in its dose optimization study of LB1148.

July 5, 2023
·
4 min read
Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series

Aeterna Zentaris Inc. today announced that Dr. Klaus Paulini, Chief Executive Officer and Eckhard Guenther, PhD, Managing Director and SVP, Business Development of Aeterna Zentaris, will participate in the Virtual Investor Summer Spotlight Series on Wednesday, July 13, 2023, at 10:00 AM ET.

July 5, 2023
·
1 min read
Drug Development

Sorrento Announces Positive Phase IIa Study Results of Abivertinib for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) and Its Plan for a Pivotal Phase III Study

Sorrento Therapeutics, Inc. (OTC: SRNEQ) today announced positive results from a China phase IIa study of Abivertinib on R/R MZL and its plan for a pivotal study.

July 5, 2023
·
8 min read
Business

Pioneer of Refractive Surgery to Join Advisory Board of Evolution Optiks

Evolution Optiks Limited announced today that Prof. Dr. Thomas Neuhann had joined the ranks of experts serving on the Advisory Board of the company.

July 5, 2023
·
2 min read